Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tofacitinib

A Janus kinase (JAK) inhibitor in tablets, the first approved for rheumatoid arthritis (United States, 2012) and later for other inflammatory diseases. It switches off, from inside the cells, the signals that drive inflammation. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?Janus kinases are named after Janus, the two-faced Roman god, because they have two almost identical halves: an active one and one that regulates it.

TofacitinibGo to the active ingredient →
TofacitinibActive ingredientTofacitinibCat. No. P-T142-001CAS 477600-75-2
DBUImpurityDBUCat. No. P-T142-050CAS 6674-22-2

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.